Fourth Quarter 2024 Highlights
- Net Sales of $3.1 billion
increased 7%; organic sales increased 7% versus year-ago
period
- GAAP Loss from continuing operations of $(61) million, operating EBITDA of $807 million
- GAAP EPS from continuing operations of $(0.17); adjusted EPS of $1.13
- Cash provided by operating activities from continuing
operations of $564 million;
transaction-adjusted free cash flow of $455
million
Full Year 2024 Highlights
- Net Sales of $12.4 billion
increased 3%; organic sales increased 1% versus prior year
- GAAP Income from continuing operations of $778 million; operating EBITDA of $3.14 billion
- GAAP EPS from continuing operations of $1.77; adjusted EPS of $4.07
- Cash provided by operating activities from continuing
operations of $2.3 billion;
transaction-adjusted free cash flow of $1.8
billion
WILMINGTON, Del., Feb. 11,
2025 /PRNewswire/ -- DuPont (NYSE: DD) announced its
financial results(1) for the fourth quarter and full
year ended December 31, 2024 and
initiated 2025 financial guidance.
"DuPont closed out a year of strong financial performance with
solid fourth quarter results as we saw continued strength in
electronics end-markets and a return to year-over-year top-line
growth in Water & Protection driven by further improvement in
water and medical packaging end-markets," said Lori Koch, DuPont Chief Executive Officer. "Our
team's ongoing focus on operational execution and cost discipline
throughout 2024 delivered 100 basis points of margin expansion with
17% adjusted EPS growth for the full year, along with strong cash
generation and related cash conversion of 105%."
"I am pleased with the progress we are making on the intended
separation of our Electronics business targeted for November 1, 2025," Koch added. "We also remain
excited for and confident in DuPont's value creation opportunities
following the Electronics separation, centered around the high
growth businesses of Water and Healthcare, along with other
market-leading industrial product lines."
Fourth Quarter 2024
Consolidated Results(1)
|
Dollars in millions,
unless noted
|
4Q'24
|
4Q'23
|
Change
vs.
4Q'23
|
Organic Sales
(2)
vs.
4Q'23
|
Net sales
|
$3,092
|
$2,898
|
7 %
|
7 %
|
GAAP Loss from
continuing operations
|
$(61)
|
$(300)
|
(80) %
|
|
Operating
EBITDA(2)
|
$807
|
$715
|
13 %
|
|
Operating EBITDA
margin(2) %
|
26.1 %
|
24.7 %
|
140 bps
|
|
GAAP EPS from
continuing operations
|
$(0.17)
|
$(0.72)
|
(76) %
|
|
Adjusted
EPS(2)
|
$1.13
|
$0.87
|
30 %
|
|
Cash provided by
operating activities – cont. ops.
|
$564
|
$646
|
(13) %
|
|
Transaction-adjusted
free cash flow(2)
|
$455
|
$501
|
(9) %
|
|
Net sales
- Net sales and organic sales(2) increased 7% due to
an 8% increase in volume, slightly offset by a 1% decrease in
price. Higher volume was led by continued strong demand in
electronics end-markets, a return to year-over-year growth in
medical packaging and biopharma within healthcare markets, and
further acceleration in water markets.
- 10% organic sales(2) growth in Electronics &
Industrial; 6% organic sales(2) growth in Water &
Protection; 7% organic sales(2) decline in the retained
businesses reported in Corporate & Other.
- 11% organic sales(2) growth in Asia Pacific; 5% organic sales(2)
growth in U.S. & Canada; 1%
organic sales(2) growth in EMEA.
GAAP Loss/Loss per share from continuing operations
- GAAP Loss/Loss per share from continuing operations improved
versus the year-ago period due to lower net charges related to
significant items, as outlined in the attached schedules, and
higher segment earnings.
Operating EBITDA(2)
- Operating EBITDA(2) increased as volume gains, the
benefit of higher production rates and savings from restructuring
actions were partially offset by higher variable compensation.
Adjusted EPS(2)
- Adjusted EPS(2) increased due primarily to higher
segment earnings, the benefit of a lower share count and tax rate,
as well as lower foreign exchange losses.
Cash provided by operating activities from continuing
operations
- Cash provided by operating activities from continuing
operations in the quarter of $564
million, capital expenditures of $161
million and separation transaction cost payments of
$52 million resulted in
transaction-adjusted free cash flow and related
conversion(2) of $455
million and 96%, respectively.
|
(1)
|
Results and cash flows
are presented on a continuing operations basis. See page 7 for
further information, including the basis of presentation included
in this release.
|
(2)
|
Organic sales,
operating EBITDA, operating EBITDA margin, adjusted EPS,
transaction-adjusted free cash flow and transaction-adjusted free
cash flow conversion are non-GAAP measures and only reflect
continuing operations. See pages 8-9 for further discussion,
including a definition of significant items. Reconciliation to the
most directly comparable GAAP measure, including details of
significant items begins on page 14 of this
communication.
|
(3)
|
During first quarter
2024, the Company realigned the management and reporting structure
of certain product lines within the three E&I lines of
business. E&I line of business revenue amounts for historical
periods have been recast to conform to the new
structure.
|
Fourth Quarter
2024 Segment Highlights
|
Electronics &
Industrial
|
Dollars in millions,
unless noted
|
4Q'24
|
4Q'23
|
Change
vs.
4Q'23
|
Organic
Sales(2)
vs.
4Q'23
|
Net sales
|
$1,506
|
$1,361
|
11 %
|
10 %
|
Operating
EBITDA
|
$457
|
$378
|
21 %
|
|
Operating EBITDA margin
%
|
30.3 %
|
27.8 %
|
250 bps
|
|
Net sales
- Net sales increased 11% on 10% organic sales(2)
growth and favorable portfolio impact of 1%.
- Organic sales(2) growth of 10% reflects an 11%
increase in volume slightly offset by a 1% decrease in price.
- Semiconductor Technologies(3) sales up
low-teens on an organic basis on continued semiconductor demand
recovery, driven primarily by AI technology applications and
stronger China demand.
- Interconnect Solutions(3) sales up low-double
digits on an organic basis reflecting broad-based end-market
strength, share gains and volume benefits from AI-driven technology
ramps.
- Industrial Solutions(3) sales up mid-single
digits on an organic basis due to improved demand for biopharma
within healthcare markets and strength in printing and packaging
applications.
Operating EBITDA
- Operating EBITDA increased as volume gains, the benefit of
higher production rates, savings from restructuring actions and a
gain related to a technology license agreement were partially
offset by higher variable compensation.
- Operating EBITDA margin of 30.3% increased 250 basis
points.
Water &
Protection
|
Dollars in millions,
unless noted
|
4Q'24
|
4Q'23
|
Change vs.
4Q'23
|
Organic
Sales(2) vs.
4Q'23
|
Net sales
|
$1,359
|
$1,277
|
6 %
|
6 %
|
Operating
EBITDA
|
$357
|
$314
|
14 %
|
|
Operating EBITDA margin
%
|
26.3 %
|
24.6 %
|
170 bps
|
|
Net sales
- Net sales and organic sales(2) increased 6% due to
an 8% increase in volume partially offset by a 2% decrease in
price.
- Safety Solutions sales up high-single digits on an
organic(2) basis driven primarily by volume gains for
medical packaging products in healthcare markets.
- Shelter Solutions sales flat on an organic(2)
basis due to headwinds in North
America construction markets offset by growth in repair and
remodel.
- Water Solutions sales up low-double digits on an
organic(2) basis driven by continued broad-based volume
recovery.
Operating EBITDA
- Operating EBITDA increased as volume gains and savings from
restructuring actions were partially offset by higher variable
compensation and the absence of certain discrete benefits recorded
in the prior year.
- Operating EBITDA margin of 26.3% increased 170 basis
points.
Full Year 2024
Consolidated Results(1)
|
Dollars in millions,
unless noted
|
FY'24
|
FY'23
|
Change
vs.
FY'23
|
Organic Sales
(2)
vs.
FY'23
|
Net sales
|
$12,386
|
$12,068
|
3 %
|
1 %
|
GAAP Income from
continuing operations
|
$778
|
$533
|
46 %
|
|
Operating
EBITDA(2)
|
$3,144
|
$2,942
|
7 %
|
|
Operating EBITDA
margin(2) %
|
25.4 %
|
24.4 %
|
100 bps
|
|
GAAP EPS from
continuing operations
|
$1.77
|
$1.09
|
62 %
|
|
Adjusted
EPS(2)
|
$4.07
|
$3.48
|
17 %
|
|
Cash provided by
operating activities – cont. ops.
|
$2,321
|
$2,191
|
6 %
|
|
Transaction-adjusted
free cash flow(2)
|
$1,806
|
$1,572
|
15 %
|
|
Net sales
- Net sales increased 3% on organic sales(2) growth of
1% and a favorable portfolio impact of 3% slightly offset by a
currency headwind of 1%.
- Organic sales(2) growth of 1% consisted of a 2%
increase in volume partially offset by a 1% decrease in price.
- 6% organic sales(2) growth in Electronics &
Industrial; 3% organic sales(2) decline in Water &
Protection; 4% organic sales(2) decline in the retained
businesses reported in Corporate.
- 5% organic sales(2) growth in Asia Pacific; 1% organic sales(2)
decline in U.S. & Canada; 4%
organic sales(2) decline in EMEA.
GAAP Income/GAAP EPS from continuing operations
- GAAP income/GAAP EPS from continuing operations increased due
to higher segment earnings and lower net charges related to
significant items, as outlined in the attached schedules.
Operating EBITDA(2)
- Operating EBITDA(2) increased as volume gains, the
benefit of higher production rates and savings from restructuring
actions were partially offset by higher variable compensation.
Adjusted EPS(2)
- Adjusted EPS(2) increase driven by higher segment
earnings and the benefit of a lower share count.
Cash provided by operating activities from continuing
operations
- Cash provided by operating activities from continuing
operations for the year of $2.3
billion, capital expenditures of $0.6
billion and separation transaction cost payments of
$64 million resulted in
transaction-adjusted free cash flow and related
conversion(2) of $1.8
billion and 105%, respectively.
Full Year 2024
Segment Highlights
|
Electronics &
Industrial
|
Dollars in millions,
unless noted
|
FY'24
|
FY'23
|
Change
vs.
FY'23
|
Organic
Sales(2)
vs.
FY'23
|
Net sales
|
$5,930
|
$5,337
|
11 %
|
6 %
|
Operating
EBITDA
|
$1,717
|
$1,472
|
17 %
|
|
Operating EBITDA margin
%
|
29.0 %
|
27.6 %
|
140 bps
|
|
Net sales
- Net sales increased 11% as organic sales(2) growth
of 6% and favorable portfolio benefit of 6% were slightly offset by
a currency headwind of 1%.
- Organic sales(2) growth of 6% reflects an 8%
increase in volume slightly offset by a 2% decrease in price.
- Semiconductor Technologies(3) sales up
high-teens on an organic basis(2) due to broad-based
semiconductor demand recovery driven primarily by AI technology
applications, advanced node transitions and higher China demand.
- Interconnect Solutions(3) sales up
high-single digits on an organic basis(2) due primarily
to broad-based end-market recovery, share gains and volume benefits
from AI-driven technology ramps.
- Industrial Solutions(3) sales down
high-single digits on an organic basis(2) driven by
channel inventory destocking for Kalrez® and in
biopharma markets, particularly during the first half of the
year.
Operating EBITDA
- Operating EBITDA increased as volume gains, the benefit of
higher production rates, savings from restructuring actions and the
earnings contribution from the Spectrum and Donatelle acquisitions
were partially offset by higher variable compensation and select
growth investments.
- Operating EBITDA margin of 29.0% increased 140 basis
points.
Water &
Protection
|
Dollars in millions,
unless noted
|
FY'24
|
FY'23
|
Change
vs.
FY'23
|
Organic
Sales(2)
vs.
FY'23
|
Net sales
|
$5,423
|
$5,633
|
(4) %
|
(3) %
|
Operating
EBITDA
|
$1,360
|
$1,388
|
(2) %
|
|
Operating EBITDA margin
%
|
25.1 %
|
24.6 %
|
50 bps
|
|
Net sales
- Net sales decreased 4% due to organic sales(2)
decline of 3% and a currency headwind of 1%.
- Organic sales(2) decline of 3% consists of a 2%
decrease in volume and a 1% decrease in price.
- Safety Solutions sales down mid-single digits on an
organic(2) basis due primarily to channel inventory
destocking for medical packaging products, particularly during the
first half of the year.
- Shelter Solutions sales flat on an organic(2)
basis due to headwinds in North
America construction markets offset by growth in repair and
remodel.
- Water Solutions sales down low-single digits on an
organic(2) basis due to distributor inventory destocking
during the first half of the year. Water Solutions sales increased
7% in the second half of 2024 versus the year-ago period.
Operating EBITDA
- Operating EBITDA decreased as productivity and savings from
restructuring actions were more than offset by the impact of volume
decline and higher variable compensation.
- Operating EBITDA margin of 25.1% increased 50 basis
points.
2025 Financial
Outlook
|
Dollars in millions,
unless noted
|
1Q'25E
|
Full Year
2025E
|
Net sales
|
~$3,025
|
$12,800 -
$12,900
|
Operating
EBITDA(2)
|
~$760
|
$3,325 -
$3,375
|
Adjusted
EPS(2)
|
~$0.95
|
$4.30 -
$4.40
|
"I am pleased with our solid fourth quarter results which capped
off a strong year of financial performance and we look to carry
this momentum into 2025," said Antonella
Franzen, Chief Financial Officer of DuPont. "We estimate
first quarter 2025 net sales of about $3.025
billion which assumes mid-single digit organic growth and a
foreign currency headwind of approximately 1.5% on a year over year
basis. Further, we estimate operating EBITDA of about
$760 million and adjusted EPS of
approximately $0.95 per share for the
first quarter."
"For full year 2025, we estimate consolidated net sales of
$12.8 to $12.9
billion, operating EBITDA of $3.325 to $3.375
billion, and adjusted EPS of $4.30 to $4.40 per
share," Franzen added. "Our full year net sales guidance assumes
mid-single digit organic growth and a foreign currency headwind of
about 1% versus last year."
Conference Call
The Company will host a live
webcast of its quarterly earnings conference call with
investors to discuss its results and business outlook beginning
today at 8:00 a.m. ET. The slide
presentation that accompanies the conference call will be posted on
the DuPont's Investor Relations Events and Presentations page. A
replay of the webcast also will be available on the DuPont's
Investor Relations Events and Presentations page following the
live event.
About DuPont
DuPont (NYSE: DD) is a global innovation
leader with technology-based materials and solutions that help
transform industries and everyday life. Our employees apply diverse
science and expertise to help customers advance their best ideas
and deliver essential innovations in key markets including
electronics, transportation, construction, water, healthcare and
worker safety. More information about the company, its businesses
and solutions can be found at www.dupont.com. Investors can access
information included on the Investor Relations section of the
website at investors.dupont.com.
DuPontTM and all products, unless otherwise noted,
denoted with TM, SM or ® are
trademarks, service marks or registered trademarks of affiliates of
DuPont de Nemours, Inc.
Overview
On May 22,
2024, DuPont announced a plan to separate each of its
Electronics and Water businesses in a tax-free manner to its
shareholders, (the "Previously Intended Business Separations"). On
January 15, 2025, DuPont announced it
is targeting November 1, 2025, for
the completion of the intended separation of the Electronics
business (the "Intended Electronics Separation"). DuPont also
announced that it would retain the Water business. The Intended
Electronics Separation will not require a shareholder vote and is
subject to satisfaction of customary conditions, including final
approval by DuPont's Board of Directors, receipt of tax opinion
from counsel, the filing and effectiveness of a Form 10
registration statement with the U.S. Securities and Exchange
Commission, applicable regulatory approvals and satisfactory
completion of financing.
Effective in the first quarter 2025, in light of the Intended
Electronics Separation, the Company will realign its management and
reporting structure. This realignment will result in a change in
reportable segments in the first quarter of 2025 which will change
the manner in which the Company reports its financial results by
segment (the "2025 Segment Realignment"), principally with the
businesses comprising the Intended Electronics Separation to be
reported as a single reportable segment. The businesses that
comprise the Intended Electronics Separation are the businesses
that currently comprise Semiconductor and Interconnect Solutions,
as well as the electronics businesses that are currently part of
Industrial Solutions. The discussion of results, including the
financial measures further discussed below, are not reflective of
the 2025 Segment Realignment.
Effective as of January 1, 2024,
Electronics & Industrial realigned certain product lines that
comprise its business units (Industrial Solutions, Interconnect
Solutions and Semiconductor Technologies) that are intended to
optimize business operations across the segment leading to enhanced
value for our customers and cost savings. The Net Trade Revenue by
Segment and Business or Major Product Line has been recast for all
periods presented to reflect the new structure. The realignment did
not result in changes to total Electronics and Industrial segment
net sales.
On November 1, 2023, DuPont
completed the divestiture of the Delrin® acetal homopolymer (H-POM)
business to TJC LP, (the "Delrin® Divestiture"). The results of
operations for the three and twelve months ended December 31, 2023 present the financial results
of the Delrin® Divestiture as discontinued operations. Unless
otherwise indicated, the discussion of results, including the
financial measures further discussed below, refers only to DuPont's
Continuing Operations and does not include discussion of balances
or activity of the Delrin® Divestiture.
Cautionary Statement about Forward-looking
Statements
This communication contains "forward-looking
statements" within the meaning of the federal securities laws,
including Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended.
In this context, forward-looking statements often address expected
future business and financial performance and financial condition,
and often contain words such as "expect," "anticipate," "intend,"
"plan," "believe," "seek," "see," "will," "would," "target,
"outlook," "stabilization," "confident," "preliminary," "initial,"
and similar expressions and variations or negatives of these words.
All statements, other than statements of historical fact, are
forward-looking statements, including statements regarding outlook,
expectations and guidance. Forward-looking statements address
matters that are, to varying degrees, uncertain and subject to
risks, uncertainties, and assumptions, many of which that are
beyond DuPont's control, that could cause actual results to differ
materially from those expressed in any forward-looking
statements.
Forward-looking statements are not guarantees of future results.
Some of the important factors that could cause DuPont's actual
results to differ materially from those projected in any such
forward-looking statements include, but are not limited to: (i) the
ability of DuPont to effect the Intended Electronics Separation and
to meet the conditions related thereto; (ii) the possibility that
the Intended Electronics Separation will not be completed within
the anticipated time period or at all; (iii) the possibility that
the Intended Electronics Separation will not achieve its intended
benefits; (iv) the impact of Intended Electronics Separation on
DuPont's businesses and the risk that the separation may be more
difficult, time-consuming or costly than expected, including the
impact on DuPont's resources, systems, procedures and controls,
diversion of management's attention and the impact and possible
disruption of existing relationships with customers, suppliers,
employees and other business counterparties; (v) the possibility of
disruption, including disputes, litigation or unanticipated costs,
in connection with the Intended Electronics Separation; (vi) the
uncertainty of the expected financial performance of DuPont or the
separated company following completion of the Intended Electronics
Separation; (vii) negative effects of the announcement or pendency
of the Intended Electronics Separation on the market price of
DuPont's securities and/or on the financial performance of DuPont;
(viii) the ability to achieve anticipated capital structures in
connection with Intended Electronics Separation, including the
future availability of credit and factors that may affect such
availability; (ix) the ability to achieve anticipated credit
ratings in connection with the Intended Electronics Separation; (x)
the ability to achieve anticipated tax treatments in connection
with the Intended Electronics Separation and completed and future,
if any, divestitures, mergers, acquisitions and other portfolio
changes and the impact of changes in relevant tax and other laws;
(xi) risks and costs related to each of the parties respective
performance under and the impact of the arrangement to share future
eligible PFAS costs by and among DuPont, Corteva and Chemours,
including the outcome of any pending or future litigation related
to PFAS or PFOA, including personal injury claims and natural
resource damages claims; the extent and cost of ongoing remediation
obligations and potential future remediation obligations; and
changes in laws and regulations applicable to PFAS chemicals; (xii)
indemnification of certain legacy liabilities; (xiii) the failure
to realize expected benefits and effectively manage and achieve
anticipated synergies and operational efficiencies in connection
with the Intended Electronics Separation and completed and future,
if any, divestitures, mergers, acquisitions, and other portfolio
management, productivity and infrastructure actions; (xiv) the
risks and uncertainties, including increased costs and the ability
to obtain raw materials and meet customer needs from, among other
events, pandemics and responsive actions; (xv) adverse changes in
worldwide economic, political, regulatory, international trade,
geopolitical, capital markets and other external conditions; and
other factors beyond DuPont's control, including inflation,
recession, military conflicts, natural and other disasters or
weather-related events, that impact the operations of DuPont, its
customers and/or its suppliers; (xvi) the ability to offset
increases in cost of inputs, including raw materials, energy and
logistics; (xvii) the risks associated with continuing or expanding
trade disputes or restrictions, new or increased tariffs or export
controls including on exports to China of U.S.-regulated products and
technology; (xviii) the risks, including ability to achieve, and
costs associated with DuPont's sustainability strategy, including
the actual conduct of DuPont's activities and results thereof, and
the development, implementation, achievement or continuation of any
goal, program, policy or initiative discussed or expected; (xix)
other risks to DuPont's business and operations, including the risk
of impairment; and (xx) other risk factors discussed in DuPont's
most recent annual report and subsequent current and periodic
reports filed with the U.S. Securities and Exchange Commission.
Unlisted factors may present significant additional obstacles to
the realization of forward-looking statements. Consequences of
material differences in results as compared with those anticipated
in the forward-looking statements could include, among other
things, business or supply chain disruption, operational problems,
financial loss, legal liability to third parties and similar risks,
any of which could have a material adverse effect on DuPont's
consolidated financial condition, results of operations, credit
rating or liquidity. You should not place undue reliance on
forward-looking statements, which speak only as of the date they
are made. DuPont assumes no obligation to publicly provide
revisions or updates to any forward-looking statements whether as a
result of new information, future developments or otherwise, should
circumstances change, except as otherwise required by securities
and other applicable laws.
Non-GAAP Financial Measures
Unless otherwise
indicated, all financial metrics presented reflect continuing
operations only.
This communication includes information that does not conform to
accounting principles generally accepted in the United States of America ("U.S. GAAP") and
are considered non-GAAP measures. Management uses these measures
internally for planning, forecasting and evaluating the performance
of the Company, including allocating resources. DuPont's management
believes these non-GAAP financial measures are useful to investors
because they provide additional information related to the ongoing
performance of DuPont to offer a more meaningful comparison related
to future results of operations. These non-GAAP financial measures
supplement disclosures prepared in accordance with U.S. GAAP, and
should not be viewed as an alternative to U.S. GAAP. Furthermore,
such non-GAAP measures may not be consistent with similar measures
provided or used by other companies. Reconciliations for these
non-GAAP measures to U.S. GAAP are provided in the Selected
Financial Information and Non-GAAP Measures starting on page 14 and
in the Reconciliation to Non-GAAP Measures on the Investors section
of the Company's website. Non-GAAP measures included in this
communication are defined below. The Company has not provided
forward-looking U.S. GAAP financial measures or a reconciliation of
forward-looking non-GAAP financial measures to the most comparable
U.S. GAAP financial measures on a forward-looking basis because the
Company is unable to predict with reasonable certainty the ultimate
outcome of certain future events. These events include, among
others, the impact of portfolio changes, including asset sales,
mergers, acquisitions, and divestitures; contingent liabilities
related to litigation, environmental and indemnifications matters;
impairments and discrete tax items. These items are uncertain,
depend on various factors, and could have a material impact on U.S.
GAAP results for the guidance period.
Indirect costs, such as those related to corporate and shared
service functions previously allocated to the Delrin® Divestiture,
do not meet the criteria for discontinued operations and were
reported within continuing operations in the respective prior
periods. A portion of these historical indirect costs include costs
related to activities the Company is undertaking on behalf of
Delrin® and for which it is reimbursed ("Future Reimbursable
Indirect Costs"). Future Reimbursable Indirect Costs are reported
within continuing operations but are excluded from operating EBITDA
as defined below. The remaining portion of these indirect costs is
not subject to future reimbursement ("Stranded Costs"). Stranded
Costs are reported within continuing operations in Corporate &
Other and are included within Operating EBITDA.
Adjusted Earnings is defined as income from continuing
operations excluding the after-tax impact of significant items,
after-tax impact of amortization expense of intangibles, the
after-tax impact of non-operating pension / other post employment
benefits ("OPEB") credits / costs and Future Reimbursable Indirect
Costs. Adjusted Earnings is the numerator used in the calculation
of Adjusted EPS, as well as the denominator in Adjusted Free Cash
Flow Conversion.
Adjusted EPS is defined as Adjusted Earnings per common share -
diluted. Management estimates amortization expense in 2025
associated with intangibles to be about $590
million on a pre-tax basis, or approximately $1.08 per share.
The Company's measure of profit/loss for segment reporting
purposes is Operating EBITDA as this is the manner in which the
Company's chief operating decision maker ("CODM") assesses
performance and allocates resources. The Company defines Operating
EBITDA as earnings (i.e., "Income from continuing operations before
income taxes") before interest, depreciation, amortization,
non-operating pension / OPEB benefits / charges, and foreign
exchange gains / losses, excluding Future Reimbursable Indirect
Costs, and adjusted for significant items. Reconciliations of these
measures are provided on the following pages.
Operating EBITDA Margin is defined as Operating EBITDA divided
by Net Sales.
Incremental Margin is the change in Operating EBITDA divided by
the change in Net Sales for the applicable period.
Significant items are items that arise outside the ordinary
course of the Company's business that management believes may cause
misinterpretation of underlying business performance, both
historical and future, based on a combination of some or all of the
item's size, unusual nature and infrequent occurrence. Management
classifies as significant items certain costs and expenses
associated with integration and separation activities related to
transformational acquisitions and divestitures as they are
considered unrelated to ongoing business performance.
Organic Sales is defined as net sales excluding the impacts of
currency and portfolio.
Non-GAAP Financial Measures (continued)
Adjusted Free
Cash Flow is defined as cash provided by/used for operating
activities from continuing operations less capital expenditures and
excluding the impact of cash inflows/outflows that are unusual in
nature and/or infrequent in occurrence that neither relate to the
ordinary course of the Company's business nor reflect the Company's
underlying business liquidity. As a result, Adjusted Free Cash Flow
represents cash that is available to the Company, after investing
in its asset base, to fund obligations using the Company's primary
source of liquidity, cash provided by operating activities from
continuing operations. Management believes Adjusted Free Cash Flow,
even though it may be defined differently from other companies, is
useful to investors, analysts and others to evaluate the Company's
cash flow and financial performance, and it is an integral measure
used in the Company's financial planning process. Management notes
that there were no exclusions for items that are unusual in nature
and/or infrequent in occurrence for the three and twelve-month
periods ended December 31, 2024 and
December 31, 2023.
Adjusted Free Cash Flow Conversion is defined as Adjusted Free
Cash Flow divided by Adjusted Earnings. Management uses Adjusted
Free Cash Flow Conversion as an indicator of our ability to convert
earnings to cash.
Supplemental non-GAAP financial measures are presented beginning
in the third quarter of 2024. Management believes the Intended
Electronics Separation represents a significant transformational
change for the Company and the impact of separation-related
transaction cost payments are expected to be material to the
Company's financial statements. Management believes the
supplemental non-GAAP financial measures, Transaction-Adjusted Free
Cash Flow and Transaction-Adjusted Free Cash Flow Conversion (each
defined below), provide an integral view of information on the
Company's underlying business performance during this period of
transformational change. Management believes Transaction-Adjusted
Free Cash Flow, which may be defined differently from other
companies, is useful to investors, analysts and others to evaluate
the Company's cash flow and financial performance, and it is an
integral measure used in the Company's financial planning process.
These non-GAAP financial measures are not intended to represent
residual cash flow for discretionary expenditures since other
non-discretionary expenditures, such as mandatory debt service
requirements, are not deducted from the measure.
Transaction-Adjusted Free Cash Flow is defined as cash provided
by/used for operating activities from continuing operations less
capital expenditures, separation-related transaction cost payments
and excluding the impact of cash inflows/outflows that are unusual
in nature and/or infrequent in occurrence that neither relate to
the ordinary course of the Company's business nor reflect the
Company's underlying business liquidity.
Transaction-Adjusted Free Cash Flow Conversion is defined as
Adjusted Free Cash Flow excluding separation-related transaction
costs divided by Adjusted Earnings.
DuPont de Nemours,
Inc.
Consolidated
Statements of Operations
|
In millions, except per
share amounts (Unaudited)
|
Three Months
Ended
December 31,
|
Twelve Months
Ended
December 31,
|
2024
|
2023
|
2024
|
2023
|
Net sales
|
$
3,092
|
$
2,898
|
$
12,386
|
$
12,068
|
Cost of
sales
|
1,967
|
1,868
|
7,879
|
7,835
|
Research and
development expenses
|
138
|
128
|
531
|
508
|
Selling, general and
administrative expenses
|
363
|
350
|
1,552
|
1,408
|
Amortization of
intangibles
|
146
|
152
|
595
|
600
|
Restructuring and
asset related charges - net
|
19
|
107
|
87
|
146
|
Goodwill impairment
charges
|
—
|
804
|
—
|
804
|
Acquisition,
integration and separation costs
|
117
|
5
|
168
|
20
|
Equity in earnings of
nonconsolidated affiliates
|
11
|
11
|
60
|
51
|
Sundry income
(expense) - net
|
(226)
|
(10)
|
(76)
|
102
|
Interest
expense
|
84
|
101
|
366
|
396
|
Income (loss) from
continuing operations before income taxes
|
$
43
|
$
(616)
|
$
1,192
|
$
504
|
Provision for (benefit
from) income taxes on continuing operations
|
104
|
(316)
|
414
|
(29)
|
(Loss) income from
continuing operations, net of tax
|
$
(61)
|
$
(300)
|
$
778
|
$
533
|
(Loss) income from
discontinued operations, net of tax
|
(45)
|
286
|
(40)
|
(71)
|
Net (loss)
income
|
$
(106)
|
$
(14)
|
$
738
|
$
462
|
Net income
attributable to noncontrolling interests
|
12
|
8
|
35
|
39
|
Net (loss) income
available for DuPont common stockholders
|
$
(118)
|
$
(22)
|
$
703
|
$
423
|
|
Per common share
data:
|
|
|
|
|
(Loss) earnings per
common share from continuing operations - basic
|
$
(0.17)
|
$
(0.72)
|
$
1.77
|
$
1.10
|
(Loss) earnings per
common share from discontinued operations - basic
|
(0.11)
|
0.66
|
(0.10)
|
(0.16)
|
(Loss) earnings per
common share - basic
|
$
(0.28)
|
$
(0.05)
|
$
1.68
|
$
0.94
|
(Loss) earnings per
common share from continuing operations - diluted
|
$
(0.17)
|
$
(0.72)
|
$
1.77
|
$
1.09
|
(Loss) earnings per
common share from discontinued operations - diluted
|
(0.11)
|
0.66
|
(0.10)
|
(0.16)
|
(Loss) earnings per
common share - diluted
|
$
(0.28)
|
$
(0.05)
|
$
1.67
|
$
0.94
|
|
Weighted-average common
shares outstanding - basic
|
418.3
|
430.3
|
419.2
|
449.9
|
Weighted-average common
shares outstanding - diluted
|
418.3
|
430.3
|
420.6
|
451.2
|
DuPont de Nemours,
Inc.
Condensed
Consolidated Balance Sheets
|
In millions, except
share amounts (Unaudited)
|
December 31.
2024
|
December 31,
2023
|
Assets
|
|
|
Current
Assets
|
|
|
Cash and cash
equivalents
|
$
1,850
|
$
2,392
|
Restricted cash and
cash equivalents
|
6
|
411
|
Accounts and notes
receivable - net
|
2,199
|
2,370
|
Inventories
|
2,130
|
2,147
|
Prepaid and other
current assets
|
179
|
194
|
Total current
assets
|
$
6,364
|
$
7,514
|
Property, plant and
equipment - net of accumulated depreciation (December 31, 2024
- $5,188; December 31, 2023 - $4,841)
|
5,768
|
5,884
|
Other Assets
|
|
|
Goodwill
|
16,567
|
16,720
|
Other intangible
assets
|
5,370
|
5,814
|
Restricted cash and
cash equivalents - noncurrent
|
36
|
—
|
Investments and
noncurrent receivables
|
1,081
|
1,071
|
Deferred income tax
assets
|
246
|
312
|
Deferred charges and
other assets
|
1,204
|
1,237
|
Total other
assets
|
$
24,504
|
$
25,154
|
Total Assets
|
$
36,636
|
$
38,552
|
Liabilities and
Equity
|
|
|
Current
Liabilities
|
|
|
Short-term
borrowings
|
$
1,848
|
$
—
|
Accounts
payable
|
1,720
|
1,675
|
Income taxes
payable
|
202
|
154
|
Accrued and other
current liabilities
|
1,031
|
1,269
|
Total current
liabilities
|
$
4,801
|
$
3,098
|
Long-Term
Debt
|
5,323
|
7,800
|
Other Noncurrent
Liabilities
|
|
|
Deferred income tax
liabilities
|
915
|
1,130
|
Pension and other
post-employment benefits - noncurrent
|
523
|
565
|
Other noncurrent
obligations
|
1,281
|
1,234
|
Total other noncurrent
liabilities
|
$
2,719
|
$
2,929
|
Total
Liabilities
|
$
12,843
|
$
13,827
|
Commitments and
contingent liabilities
|
|
|
Stockholders'
Equity
|
|
|
Common stock
(authorized 1,666,666,667 shares of $0.01 par value each;
issued
2024: 417,994,343 shares; 2023: 430,110,140
shares)
|
4
|
4
|
Additional paid-in
capital
|
47,922
|
48,059
|
Accumulated
deficit
|
(23,076)
|
(22,874)
|
Accumulated other
comprehensive loss
|
(1,500)
|
(910)
|
Total DuPont
stockholders' equity
|
$
23,350
|
$
24,279
|
Noncontrolling
interests
|
443
|
446
|
Total
equity
|
$
23,793
|
$
24,725
|
Total Liabilities and
Equity
|
$
36,636
|
$
38,552
|
DuPont de Nemours,
Inc.
Consolidated
Statement of Cash Flows
|
(In millions) For the
years ended December 31,
|
2024
|
2023
|
Operating
Activities
|
|
|
Net income
|
$
738
|
$
462
|
Loss from discontinued
operations
|
(40)
|
(71)
|
Net income from
continuing operations
|
$
778
|
$
533
|
Adjustments to
reconcile net income to net cash provided by operating
activities:
|
|
|
Depreciation and
amortization
|
1,194
|
1,147
|
Credit for deferred
income tax and other tax related items
|
(163)
|
(381)
|
Earnings of
nonconsolidated affiliates less than dividends received
|
13
|
20
|
Net periodic pension
benefit (credit) cost
|
(1)
|
31
|
Periodic benefit plan
contributions
|
(51)
|
(63)
|
Net gain on sales,
businesses and investments
|
(20)
|
(19)
|
Restructuring and
asset related charges - net
|
87
|
146
|
Stock based
compensation
|
77
|
74
|
Goodwill impairment
charge
|
—
|
804
|
Loss on debt
extinguishment
|
74
|
—
|
Interest rate swap
loss
|
138
|
—
|
Other net (income)
loss
|
(27)
|
54
|
Changes in assets and
liabilities, net of effects of acquired and divested
companies:
|
|
|
Accounts and notes
receivable
|
(135)
|
202
|
Inventories
|
(7)
|
227
|
Accounts
payable
|
77
|
(310)
|
Other assets and
liabilities, net
|
287
|
(274)
|
Cash provided by
operating activities - continuing operations
|
2,321
|
2,191
|
Investing
Activities
|
|
|
Capital
expenditures
|
(579)
|
(619)
|
Proceeds from sales of
property, businesses, and ownership interests in nonconsolidated
affiliates, net of cash divested
|
8
|
1,244
|
Acquisitions of
property and businesses, net of cash acquired
|
(321)
|
(1,761)
|
Purchases of
investments
|
—
|
(32)
|
Proceeds from sales
and maturities of investments
|
—
|
1,334
|
Other investing
activities, net
|
43
|
6
|
Cash (used for)
provided by investing activities - continuing operations
|
(849)
|
172
|
Financing
Activities
|
|
|
Payments on long-term
debt
|
(687)
|
(300)
|
Purchases of common
stock and forward contracts
|
(500)
|
(2,000)
|
Proceeds from issuance
of Company stock
|
50
|
27
|
Employee taxes paid
for share-based payment arrangements
|
(27)
|
(27)
|
Distributions to
noncontrolling interests
|
(26)
|
(37)
|
Dividends paid to
stockholders
|
(635)
|
(651)
|
Payment of excise tax
on purchase of treasury stock
|
(21)
|
—
|
Other financing
activities, net
|
(1)
|
(1)
|
Cash used for
financing activities - continuing operations
|
(1,847)
|
(2,989)
|
Cash Flows from
Discontinued Operations
|
|
|
Cash used for
operations - discontinued operations
|
(474)
|
(273)
|
Cash used for
investing activities - discontinued operations
|
—
|
(33)
|
Cash used for
financing activities - discontinued operations
|
—
|
—
|
Cash used in
discontinued operations
|
(474)
|
(306)
|
Effect of exchange rate
changes on cash, cash equivalents and restricted cash
|
(62)
|
(37)
|
Decrease in cash,
cash equivalents and restricted cash
|
(911)
|
(969)
|
Cash, cash equivalents
and restricted cash from continuing operations, beginning of
period
|
2,803
|
3,772
|
Cash, cash equivalents
and restricted cash from discontinued operations, beginning of
period
|
—
|
—
|
Cash, cash
equivalents and restricted cash at beginning of
period
|
2,803
|
3,772
|
Cash, cash equivalents
and restricted cash from continuing operations, end of
period
|
1,892
|
2,803
|
Cash, cash equivalents
and restricted cash from discontinued operations, end of
period
|
—
|
—
|
Cash, cash
equivalents and restricted cash at end of period
|
$
1,892
|
$
2,803
|
DuPont de Nemours,
Inc.
Net Sales by
Segment and Geographic Region
|
Net Sales by Segment
and Geographic Region
|
Three Months
Ended
|
Twelve Months
Ended
|
In millions
(Unaudited)
|
Dec 31,
2024
|
Dec 31,
2023
|
Dec 31,
2024
|
Dec 31,
2023
|
Electronics &
Industrial
|
$
1,506
|
$
1,361
|
$
5,930
|
$
5,337
|
Water &
Protection
|
1,359
|
1,277
|
5,423
|
5,633
|
Corporate & Other
1
|
227
|
260
|
1,033
|
1,098
|
Total
|
$
3,092
|
$
2,898
|
$
12,386
|
$
12,068
|
U.S. &
Canada
|
$
1,083
|
$
1,024
|
$
4,375
|
$
4,185
|
EMEA
2
|
514
|
501
|
2,146
|
2,203
|
Asia Pacific
3
|
1,373
|
1,246
|
5,368
|
5,191
|
Latin
America
|
122
|
127
|
497
|
489
|
Total
|
$
3,092
|
$
2,898
|
$
12,386
|
$
12,068
|
Net Sales Variance
by Segment
and Geographic Region
|
Three Months Ended
December 31, 2024
|
Local Price
&
Product Mix
|
Volume
|
Total
Organic
|
Currency
|
Portfolio /
Other
|
Total
|
Percent change from
prior year
(Unaudited)
|
Electronics &
Industrial
|
(1) %
|
11 %
|
10 %
|
— %
|
1 %
|
11 %
|
Water &
Protection
|
(2)
|
8
|
6
|
—
|
—
|
6
|
Corporate & Other
1
|
—
|
(7)
|
(7)
|
—
|
(6)
|
(13)
|
Total
|
(1) %
|
8 %
|
7 %
|
— %
|
— %
|
7 %
|
U.S. &
Canada
|
(1) %
|
6 %
|
5 %
|
— %
|
1 %
|
6 %
|
EMEA2
|
(2)
|
3
|
1
|
1
|
1
|
3
|
Asia Pacific
3
|
(2)
|
13
|
11
|
—
|
(1)
|
10
|
Latin
America
|
(2)
|
(2)
|
(4)
|
—
|
—
|
(4)
|
Total
|
(1) %
|
8 %
|
7 %
|
— %
|
— %
|
7 %
|
Net Sales Variance
by Segment
and Geographic Region
|
Twelve Months Ended
December 31, 2024
|
Local Price
&
Product Mix
|
Volume
|
Total
Organic
|
Currency
|
Portfolio /
Other
|
Total
|
Percent change from
prior year
(Unaudited)
|
Electronics &
Industrial
|
(2) %
|
8 %
|
6 %
|
(1) %
|
6 %
|
11 %
|
Water &
Protection
|
(1)
|
(2)
|
(3)
|
(1)
|
—
|
(4)
|
Corporate & Other
1
|
(1)
|
(3)
|
(4)
|
(1)
|
(1)
|
(6)
|
Total
|
(1) %
|
2 %
|
1 %
|
(1) %
|
3 %
|
3 %
|
U.S. &
Canada
|
— %
|
(1) %
|
(1) %
|
— %
|
6 %
|
5 %
|
EMEA2
|
(2)
|
(2)
|
(4)
|
—
|
1
|
(3)
|
Asia Pacific
3
|
(2)
|
7
|
5
|
(2)
|
—
|
3
|
Latin
America
|
(1)
|
—
|
(1)
|
—
|
3
|
2
|
Total
|
(1) %
|
2 %
|
1 %
|
(1) %
|
3 %
|
3 %
|
|
|
1.
|
Net Sales within
Corporate & Other reflect the Retained Businesses which include
the Auto Adhesives & Fluids, MultibaseTM and
Tedlar® businesses.
|
2.
|
Europe, Middle East and
Africa.
|
3.
|
Net sales attributed to
China/Hong Kong, for the three months ended December 31, 2024 and
2023 were $584 million and $537 million, respectively, while for
the twelve months ended months ended December 31, 2024 and 2023 net
sales attributed to China were $2,345 million and $2,206 million
respectively.
|
DuPont de Nemours,
Inc.
Selected Financial
Information and Non-GAAP Measures
|
|
|
|
|
Operating
EBITDA by
Segment
|
Three Months
Ended
|
Twelve Months
Ended
|
|
In millions
(Unaudited)
|
Dec 31,
2024
|
Dec 31,
2023
|
Dec 31,
2024
|
Dec 31,
2023
|
|
Electronics &
Industrial
|
$
457
|
$
378
|
$
1,717
|
$
1,472
|
|
Water &
Protection
|
357
|
314
|
1,360
|
1,388
|
|
Corporate & Other
1
|
(7)
|
23
|
67
|
82
|
|
Total
|
$
807
|
$
715
|
$
3,144
|
$
2,942
|
|
1. In addition to
corporate expenses, Corporate & Other includes activities of
the Retained Businesses which include the Auto Adhesives &
Fluids, MultibaseTM and Tedlar® businesses.
|
|
|
|
|
|
|
|
Equity in Earnings
of Nonconsolidated Affiliates by Segment
|
Three Months
Ended
|
Twelve Months
Ended
|
|
In millions
(Unaudited)
|
Dec 31,
2024
|
Dec 31,
2023
|
Dec 31,
2024
|
Dec 31,
2023
|
|
Electronics &
Industrial
|
$
4
|
$
5
|
$
37
|
$
16
|
|
Water &
Protection
|
8
|
6
|
30
|
35
|
|
Corporate & Other
1
|
(1)
|
—
|
(7)
|
—
|
|
Total equity earnings
included in operating EBITDA (GAAP)
|
$
11
|
$
11
|
$
60
|
$
51
|
|
1. Corporate &
Other includes the equity interest acquired in the Delrin®
Divestiture transaction.
|
|
|
|
|
|
|
|
|
Reconciliation of
"Income from continuing operations, net of tax" to
"Operating EBITDA"
|
Three Months
Ended
|
Twelve Months
Ended
|
|
|
In millions
(Unaudited)
|
Dec 31,
2024
|
Dec 31,
2023
|
Dec 31,
2024
|
Dec 31,
2023
|
|
(Loss) income from
continuing operations, net of tax (GAAP)
|
$
(61)
|
$
(300)
|
$
778
|
$
533
|
|
+ Provision for
(benefit from) income taxes on continuing operations
|
104
|
(316)
|
414
|
(29)
|
|
Income (loss) from
continuing operations before income taxes
|
$
43
|
$
(616)
|
$
1,192
|
$
504
|
|
+ Depreciation and
amortization
|
299
|
294
|
1,194
|
1,147
|
|
- Interest
income 1
|
18
|
23
|
73
|
155
|
|
+ Interest
expense 1, 2
|
83
|
101
|
364
|
396
|
|
- Non-operating
pension/OPEB benefit credits (costs) 1
|
4
|
(2)
|
18
|
(9)
|
|
- Foreign
exchange gains (losses), net 1
|
22
|
(42)
|
3
|
(73)
|
|
+ Future reimbursable
indirect costs
|
—
|
1
|
—
|
7
|
|
- Significant items
charge
|
(426)
|
(914)
|
(488)
|
(961)
|
|
Operating EBITDA
(non-GAAP)
|
$
807
|
$
715
|
$
3,144
|
$
2,942
|
|
|
|
1.
|
Included in "Sundry
income (expense) - net."
|
2.
|
The three month and
twelve month period ended December 31, 2024 excludes interest rate
swap basis amortization. Refer to details of significant items on
page 16.
|
Reconciliation of
"Cash provided by operating activities - continuing
operations" to Adjusted Free Cash Flow 1 , Transaction-Adjusted Free
Cash Flow1 and
calculation of "Adjusted Free Cash Flow Conversion"
and "Transaction-Adjusted Free Cash Flow Conversion"
|
Three Months
Ended
|
Twelve Months
Ended
|
In millions
(Unaudited)
|
Dec 31,
2024
|
Dec 31,
2023
|
Dec 31,
2024
|
Dec 31,
2023
|
Cash provided by
operating activities (GAAP) 2 - continuing
operations
|
$
564
|
$
646
|
$
2,321
|
$
2,191
|
Capital
expenditures
|
(161)
|
(145)
|
(579)
|
(619)
|
Adjusted free cash flow
(non-GAAP)
|
$
403
|
$
501
|
$
1,742
|
$
1,572
|
Separation-related
transaction cost payments
|
52
|
—
|
64
|
—
|
Transaction-adjusted
free cash flow (non-GAAP)
|
$
455
|
$
501
|
$
1,806
|
$
1,572
|
|
|
|
|
|
Adjusted earnings
(non-GAAP) 3
|
$
476
|
$
376
|
$
1,712
|
$
1,570
|
Adjusted free cash flow
conversion (non-GAAP)
|
85 %
|
133 %
|
102 %
|
100 %
|
Transaction-adjusted
free cash flow conversion (non-GAAP)
|
96 %
|
133 %
|
105 %
|
100 %
|
|
|
1.
|
Adjusted Free Cash Flow
and Transaction-Adjusted Free Cash Flow are calculated on a
continuing operations basis for all periods presented. Refer to the
definitions of Non-GAAP metrics on pages 8-9 for additional
information.
|
2.
|
Refer to the
Consolidated Statement of Cash Flows included in the schedules
above for major GAAP cash flow categories as well as further detail
relating to the changes in "Cash provided by operating activities -
continuing operations" for the twelve month periods
noted.
|
3.
|
Refer to pages 15-16
for the Non-GAAP reconciliations of Net income from continuing
operations available for DuPont common stockholders to Adjusted
Earnings (Non-GAAP).
|
|
|
DuPont de Nemours,
Inc.
Selected Financial
Information and Non-GAAP Measures
|
Significant Items
Impacting Results for the Three Months Ended December 31,
2024
|
In millions, except per
share amounts (Unaudited)
|
Pretax 1
|
Net
Income 2
|
EPS 3
|
Income Statement
Classification
|
Reported earnings
(GAAP)
|
$
43
|
$
(73)
|
$ (0.17)
|
|
Less: Significant
items
|
|
|
|
|
Acquisition,
integration & separation costs 4
|
(117)
|
(100)
|
(0.24)
|
Acquisition,
integration and separation costs
|
Restructuring and
asset related charges - net 5
|
(19)
|
(15)
|
(0.03)
|
Restructuring and asset
related charges - net
|
Inventory write-offs
6
|
1
|
1
|
—
|
Cost of
sales
|
Interest rate swap
mark-to-market loss 7
|
(290)
|
(224)
|
(0.53)
|
Sundry income (expense)
- net
|
Interest rate swap
amortization 8
|
(1)
|
—
|
—
|
Interest
expense
|
Income tax items
9
|
—
|
(102)
|
(0.24)
|
Provision for (benefit
from) income taxes on
continuing operations
|
Total significant
items
|
$ (426)
|
$ (440)
|
$ (1.04)
|
|
Less: Amortization of
intangibles
|
(146)
|
(113)
|
(0.27)
|
Amortization of
intangibles
|
Less: Non-op pension /
OPEB benefit credits
|
4
|
4
|
0.01
|
Sundry income (expense)
- net
|
Adjusted earnings
(non-GAAP)
|
$
611
|
$
476
|
$ 1.13
|
|
Significant Items
Impacting Results for the Three Months Ended December 31,
2023
|
In millions, except per
share amounts (Unaudited)
|
Pretax 1
|
Net
Income 2
|
EPS 3
|
Income Statement
Classification
|
Reported earnings
(GAAP)
|
$ (616)
|
$ (308)
|
$ (0.72)
|
|
Less: Significant
items
|
|
|
|
|
Acquisition,
integration & separation costs 10
|
(5)
|
(4)
|
(0.01)
|
Acquisition,
integration and separation costs
|
Restructuring and
asset related charges - net 5
|
(107)
|
(81)
|
(0.19)
|
Restructuring and asset
related charges - net
|
Goodwill impairment
charge 11
|
(804)
|
(804)
|
(1.86)
|
Goodwill impairment
charges
|
Gain on
divestiture
|
2
|
1
|
—
|
Sundry income (expense)
- net
|
Income tax items
12
|
—
|
324
|
0.75
|
Provision for (benefit
from) income taxes on
continuing operations
|
Total significant
items
|
$ (914)
|
$ (564)
|
$ (1.31)
|
|
Less: Amortization of
intangibles
|
(152)
|
(118)
|
(0.27)
|
Amortization of
intangibles
|
Less: Non-op pension /
OPEB benefit costs
|
(2)
|
(2)
|
(0.01)
|
Sundry income (expense)
- net
|
Less: Future
reimbursable indirect costs
|
(1)
|
—
|
—
|
Selling, general and
administrative expenses
|
Adjusted earnings
(non-GAAP)
|
$
453
|
$
376
|
$ 0.87
|
|
|
|
1.
|
Income (loss) from
continuing operations before income taxes.
|
2.
|
Net income (loss) from
continuing operations available for DuPont common stockholders. The
income tax effect on significant items was calculated based upon
the enacted tax laws and statutory income tax rates applicable in
the tax jurisdiction(s) of the underlying non-GAAP
adjustment.
|
3.
|
Earnings (loss) per
common share from continuing operations - diluted.
|
4.
|
Acquisition,
integration and separation costs are related to the Previously
Intended Business Separations and the Intended Electronics
Separation.
|
5.
|
Includes restructuring
actions and asset related charges.
|
6.
|
Reflects an adjustment
to raw material inventory write-offs recorded in "Cost of Sales" in
connection with restructuring actions related to plant line
closures within the Water & Protection segment.
|
7.
|
Includes the non-cash
mark-to-market loss related to the 2022 Swaps and 2024 Swaps and
net interest settlement loss related to the 2022 Swaps.
|
8.
|
Reflects the basis
amortization on the 2022 Swaps.
|
9.
|
Reflects the tax
impacts of internal restructurings related to the Intended
Electronics Separation.
|
10.
|
Acquisition,
integration and separation costs related to the Spectrum
acquisition.
|
11.
|
Reflects a non-cash
goodwill impairment charge in the Protection Reporting unit
(aggregation of the Safety and Shelter businesses).
|
12.
|
Reflects the global
income tax impact of an internal restructuring involving certain
foreign subsidiaries.
|
DuPont de Nemours,
Inc.
Selected Financial
Information and Non-GAAP Measures
|
Significant Items
Impacting Results for the Twelve Months Ended December 31,
2024
|
In millions, except per
share amounts (Unaudited)
|
Pretax 1
|
Net
Income 2
|
EPS 3
|
Income Statement
Classification
|
Reported results
(GAAP)
|
$ 1,192
|
$
743
|
$ 1.77
|
|
Less: Significant
items
|
|
|
|
|
Acquisition,
integration and separation costs 4
|
(168)
|
(144)
|
(0.34)
|
Acquisition,
integration and separation costs
|
Restructuring and
asset related charges - net 5
|
(87)
|
(65)
|
(0.15)
|
Restructuring and asset
related charges - net
|
Inventory write-offs
6
|
(25)
|
(19)
|
(0.05)
|
Cost of
sales
|
Inventory step-up
amortization 7
|
(2)
|
(1)
|
—
|
Cost of
sales
|
Loss on debt
extinguishment 8
|
(74)
|
(57)
|
(0.14)
|
Sundry income (expense)
- net
|
Interest rate swap
mark-to-market loss 9
|
(138)
|
(106)
|
(0.26)
|
Sundry income (expense)
- net
|
Interest rate swap
amortization 10
|
(2)
|
(1)
|
—
|
Interest
expense
|
Income tax items
11
|
8
|
(131)
|
(0.31)
|
Sundry income (expense)
- net; Provision
for (benefit from) income taxes on
continuing operations
|
Total significant
items
|
$ (488)
|
$ (524)
|
$ (1.25)
|
|
Less: Amortization of
intangibles
|
(595)
|
(460)
|
(1.09)
|
Amortization of
intangibles
|
Less: Non-op pension /
OPEB benefit credits
|
18
|
15
|
0.04
|
Sundry income (expense)
- net
|
Adjusted earnings
(non-GAAP)
|
$ 2,257
|
$ 1,712
|
$ 4.07
|
|
Significant Items
Impacting Results for the Twelve Months Ended December 31,
2023
|
In millions, except per
share amounts (Unaudited)
|
Pretax 1
|
Net
Income 2
|
EPS 3
|
Income Statement
Classification
|
Reported results
(GAAP)
|
$
504
|
$
494
|
$ 1.09
|
|
Less: Significant
items
|
|
|
|
|
Acquisition,
integration and separation costs 12
|
(20)
|
(18)
|
(0.04)
|
Acquisition,
integration and separation costs
|
Restructuring and
asset related charges - net 5
|
(146)
|
(111)
|
(0.25)
|
Restructuring and asset
related charges - net
|
Goodwill impairment
charges 13
|
(804)
|
(804)
|
(1.78)
|
Goodwill impairment
charges
|
Gain on divestiture
14
|
9
|
7
|
0.02
|
Sundry income (expense)
- net
|
Income tax items
15
|
—
|
329
|
0.73
|
Provision for (benefit
from) income taxes on
continuing operations
|
Total significant
items
|
$ (961)
|
$ (597)
|
$ (1.32)
|
|
Less: Amortization of
intangibles
|
(600)
|
(468)
|
(1.04)
|
Amortization of
intangibles
|
Less: Non-op pension /
OPEB benefit costs
|
(9)
|
(7)
|
(0.02)
|
Sundry income (expense)
- net
|
Less: Future
reimbursable indirect costs
|
(7)
|
(4)
|
(0.01)
|
Selling, general and
administrative expenses
|
Adjusted earnings
(non-GAAP)
|
$ 2,081
|
$ 1,570
|
$ 3.48
|
|
|
|
1.
|
Income (loss) from
continuing operations before income taxes.
|
2.
|
Net income (loss) from
continuing operations available for DuPont common stockholders. The
income tax effect on significant items was calculated based upon
the enacted tax laws and statutory income tax rates applicable in
the tax jurisdiction(s) of the underlying non-GAAP
adjustment.
|
3.
|
Earnings (loss) per
common share from continuing operations - diluted.
|
4.
|
Acquisition,
integration and separation costs are primarily related to the
Previously Intended Business Separations, Intended Electronics
Separation and the Spectrum and Donatelle Plastics
acquisitions.
|
5.
|
Includes restructuring
actions and asset related charges.
|
6.
|
Reflects net raw
material inventory write-offs recorded in "Cost of Sales" in
connection with restructuring actions related to plant line
closures within the Water & Protection segment.
|
7.
|
Reflects the
amortization of an inventory step-up adjustment related to the
Donatelle Plastics acquisition.
|
8.
|
Reflects the loss on
extinguishment of debt related to the partial redemption of the
2038 notes.
|
9.
|
Includes the non-cash
mark-to-market loss related to the 2022 Swaps and 2024 Swaps and
net interest settlement loss related to the 2022 Swaps.
|
10.
|
Reflects the basis
amortization on the 2022 Swaps.
|
11.
|
Reflects the impact of
an indemnified international tax audit and internal restructurings
related to the Intended Electronics Separation.
|
12.
|
Acquisition,
integration and separation costs related to Spectrum
acquisition.
|
13.
|
Reflects a non-cash
goodwill impairment charge in the Protection Reporting unit
(aggregation of the Safety and Shelter businesses).
|
14.
|
Reflects post-closing
adjustments related to previously divested businesses.
|
15.
|
Reflects the global
income tax impact of an internal restructuring involving certain
foreign subsidiaries.
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/dupont-reports-fourth-quarter-and-full-year-2024-results-initiates-2025-financial-guidance-302372809.html
SOURCE DuPont